Medicines
- November 30, 2019
- 0
- Category:
- Tags: AnswerAntibioticholdMedicalMedicinesNewsResistanceToday
As the effectiveness of antibiotics wanes, scientists are looking at medications that preceded them, such as those involving metals and metalloids. Source link
Read more- November 28, 2019
- 0
- Category:
- Tags: AcceleratingDatadiseaseknowledgeLaunchesMedicinesParkinson’sPartnershipPortal
The Accelerating Medicines Partnership (AMP) program for Parkinson’s disease (PD) has launched a data portal to provide de-identified information collected from 4,298 PD patients and healthy controls to researchers working to develop effective...
Read more- November 25, 2019
- 0
- Category:
- Tags: bashesBillbillionDrugMedicinesNovartispayPelosiPharmalittlePricingSTATTrump
Good morning, everyone, and welcome to another working week. We hope the weekend respite was relaxing and invigorating because that oh-so-familiar routine of meetings, Skype calls, and endless texting has...
Read more- November 24, 2019
- 0
- Category:
- Tags: AcquiredAgreementbillioncompanyDefinitiveentersMedicinesNovartis
PARSIPPANY, N.J.--(BUSINESS WIRE)---- $MDCO--The Medicines Company (NASDAQ: MDCO) announced today that it has entered into definitive agreement in which Novartis AG will acquire The Medicines Company for $85 per share...
Read more- November 23, 2019
- 0
- Category:
- Tags: AcceleratingbrainDatadiseaseGenomeHospitalLaunchesMedical ResearchMedicinesNervous SystemParkinson’sParkinson's DiseasePartnershipPfizerPortalprogramresearchstroke
The Accelerating Medicines Partnership program for Parkinson's disease (PD) has launched a data portal to provide de-identified information collected from 4,298 PD patients and healthy controls to researchers working to...
Read more- November 17, 2019
- 0
- Category:
- Tags: AnnouncesASCVDcompanyDosingDurableInclisiranLDLCLoweringMedicinesORION10patientspotentshowedstudyTwiceYearly
PHILADELPHIA--(BUSINESS WIRE)---- $MDCO #ASCVD--The Medicines Company (NASDAQ: MDCO) today announced detailed results from ORION-10, the second of three pivotal 18-month low-density lipoprotein cholesterol (LDL-C) lowering Phase 3 clinical studies of...
Read more- November 13, 2019
- 0
- Category:
- Tags: #healthcareAfricaAnnouncesAvailabilitybroadencancerCellClinical TrialHealth SystemsMalariamedicineMedicinesNovartisPatientReachresearchsickle cell diseasestrategySubSaharan
Novartis announced today a new strategy to broaden patient reach and availability of its portfolio of medicines in sub-Saharan Africa, which is home to the largest underserved patient population in...
Read more- November 12, 2019
- 0
- Category:
- Tags: brainchangesessentialfunctionlong-durationMedicinesMissionsMultiplepatientssclerosisspacestructurestudyUnderscores
In December 2018 MSIF submitted an application to the World Health Organization, to add MS treatments to the Essential Medicines List. Source link
Read more- November 12, 2019
- 0
- Category:
- Tags: AcademyAgencyAmericancoverageepidemicfinancialHospitalizationsimpactinfantsItalianlimitedMedicinesPalivizumabPediatricsPretermprophylaxisrecommendationreportsResultingReviewRSVassociatedseasonSystematic
The only pharmacologic prophylaxis against respiratory syncytial virus (RSV) infection in preterm infants is the humanized monoclonal antibody palivizumab. After the 2014 modification of the American Academy o... Source link
Read moreAt nearly every major industry conference — from HLTH to CNS Summit, Exponential Medicine, and Rock Health Summit — speakers are talking about the benefits of decentralized clinical trials and digital...
Read more- October 30, 2019
- 0
- Category:
- Tags: actionsactivationCellsCFTRchannelscoloniccomponentsEpitheliumexertHerbalJapaneseKampoLAXATIVEMedicines
Herbal components of Japanese Kampo medicines exert laxative actions in colonic epithelium cells via activation of BK and CFTR channels Source link
Read moreAfter years of frustration, Vertex Pharmaceuticals struck a deal with the U.K. government to supply its cystic fibrosis medicines, capping an end to a dispute that had become a symbol...
Read more- October 20, 2019
- 0
- Category:
- Tags: AgesAnnouncesaustraliaCFTRchildrencysticEligibleFibrosisivacaftorlumacaftorivacaftorMedicinesMutationsolderORKAMBIpatientsreimbursementSymdekoTezacaftorIvacaftorVertex
LONDON--(BUSINESS WIRE)--Vertex announced reimbursement of SYMDEKO for eligible patients ages 12 and older, and ORKAMBI for children ages 2 to 5 in Australia. Source link
Read moreThe European Medicines Agency has recommended that the world's first Ebola vaccine be approved, after it was administered to hundreds of thousands of people in Africa. Source link
Read more- October 17, 2019
- 0
- Category:
- Tags: ACCESScontinuehepatitisMedicaidMedicinesprogramsrestrictSTATState
Despite guidance from the federal government, most state Medicaid programs continue to deny hepatitis C treatments to beneficiaries, although more states are gradually easing restrictions, according to a new analysis....
Read moreKARACHI: The Hepatitis Centers run by the Hepatitis Prevention & Control Program Sindh across Sindh have been facing a grave shortage of Hepatitis C medication for the past several months...
Read moreNo medicines shortages anticipated by Medicines for Ireland even in no-deal Brexit scenario This story continues at Threat of Brexit-inspired medicines shortages dismissed Or just read more coverage at Irish...
Read moreThe Alabama Board of Pharmacy is weighing whether to renew a permit for Sun Pharmaceuticals (SUNPHARMA) to distribute its medicines in the state after discovering the company was shipping products...
Read more- September 20, 2019
- 0
- Category:
- Tags: cannabisCatch22GreatestHistoryimportanceMedicalMedicinesMovementPediatricianspoliticsscience
Clinical Pediatrics, Ahead of Print. Source link
Read moreAfter protracted haggling, Vertex Pharmaceuticals struck a five-year deal with the Scottish government to provide its cystic fibrosis treatments at a “confidential discount,” a notable win for the drug maker...
Read more